Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Greenberg

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost of depression: current assessment and future directionsP E Greenberg, S A Birnbaum
Health Care Management (Philadelphia, Pa.)|September 5, 1995
Consolidation and restructuring: the next step in managed careP M Danzon, L G Boothman, P E Greenberg
Expert Opinion on Pharmacotherapy|May 5, 2001
Assessing the economic impact of psychiatric disorders: where to begin?P E Greenberg, S A Leong, H G Birnbaum
The Annals of Pharmacotherapy|September 20, 1997
Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemiaS N Finkelstein, S L Huber, P E Greenberg
Business and Health|August 6, 1995
Calculating the workplace cost of chronic diseaseP E Greenberg, S N Finkelstein, E R Berndt
The Journal of Clinical Psychiatry|November 1, 1993
The economic burden of depression in 1990P E Greenberg, L E Stiglin, S N Finkelstein, et al.
The Journal of Clinical Psychiatry|November 1, 1993
Depression: a neglected major illnessP E Greenberg, L E Stiglin, S N Finkelstein, et al.
Journal of Occupational and Environmental Medicine|February 24, 2001
Impact of illness and its treatment on workplace costs: regulatory and measurement issuesP E Greenberg, H G Birnbaum, R C Kessler, et al.
Archives of Internal Medicine|December 26, 2001
Economic burden of pneumonia in an employed populationH G Birnbaum, M Morley, P E Greenberg, et al.
Journal of Occupational and Environmental Medicine|April 5, 2001
The effects of chronic medical conditions on work loss and work cutbackR C Kessler, P E Greenberg, K D Mickelson, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Cost of depression: current assessment and future directionsP E Greenberg, S A Birnbaum
Health Care Management (Philadelphia, Pa.)|September 5, 1995
Consolidation and restructuring: the next step in managed careP M Danzon, L G Boothman, P E Greenberg
Expert Opinion on Pharmacotherapy|May 5, 2001
Assessing the economic impact of psychiatric disorders: where to begin?P E Greenberg, S A Leong, H G Birnbaum
The Annals of Pharmacotherapy|September 20, 1997
Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemiaS N Finkelstein, S L Huber, P E Greenberg
Business and Health|August 6, 1995
Calculating the workplace cost of chronic diseaseP E Greenberg, S N Finkelstein, E R Berndt
The Journal of Clinical Psychiatry|November 1, 1993
The economic burden of depression in 1990P E Greenberg, L E Stiglin, S N Finkelstein, et al.
The Journal of Clinical Psychiatry|November 1, 1993
Depression: a neglected major illnessP E Greenberg, L E Stiglin, S N Finkelstein, et al.
Journal of Occupational and Environmental Medicine|February 24, 2001
Impact of illness and its treatment on workplace costs: regulatory and measurement issuesP E Greenberg, H G Birnbaum, R C Kessler, et al.
Archives of Internal Medicine|December 26, 2001
Economic burden of pneumonia in an employed populationH G Birnbaum, M Morley, P E Greenberg, et al.
Journal of Occupational and Environmental Medicine|April 5, 2001
The effects of chronic medical conditions on work loss and work cutbackR C Kessler, P E Greenberg, K D Mickelson, et al.
Pageof 2